Products of Stemtrix Corporation

Our development as an alternative to antibiotics. The drugs are intended as a therapeutic and preventive means for infections of bacterial nature. The drugs do not include antibiotics.

Component of feeds
The active substances of the drug are natural components of the diets of farm animals and birds used in medicine and food industry

No resistance
The active ingredients of the drug are natural regulators of metabolic processes in the bacterial cell, as a result the bacterial cell has no mechanisms of resistance

Without destruction
The drugs will suppress virulence, pathogenicity of pathogenic bacteria, without resorting to the principle of direct destruction of the bacterium

Immune system
The preparations also include substances that modulate the immune response to the introduction of pathogenic bacteria into the body

Drugs can be used in the treatment of a large number of diseases

  • Gastrointestinal tract (GI tract): inflammatory bowel disease, colitis, ulcers and erosion.
  • Urogenital pathways: urethritis, cystitis, endometritis, mastit.
  • Skin: skin and subcutaneous tissue infections, pyoderma, eczema, scabies, dermatitis, acne.
Antibacterial action is based on the interaction of our drugs with transport systems associated with the membranes of bacterial cells. Instead of killing the bacteria, the drugs put them into a vegetative state, blocking their ability to cause disease.

Stemtrix preparations are involved in the natural processes of regulating the vital activity of microorganisms at the interspecific level in the composition of bacterial communities, and this implies the absence of mechanisms of resistance of bacteria to substances of this group.

The drugs have a pronounced and proven antibacterial effect against pathogenic strains, such as: Staphylococcus aureus, Streptococcus, Klebsiella spp, Escherichia coli, etc.

Our solution will effectively prevent the colonization of humans and animals by pathogens and significantly limit the use of antibiotics, while maintaining proper performance indicators. The structure of molecules and the physicochemical properties of the proposed preparations make it relatively easy to modify their molecular structure to increase the target pharmacological activity.

Drugs for animals

Animal Medicine

Rezovet®

Status:

Prevention and treatment of poultry in bacterial diseases

Read More

Animal Medicine

Rezomast®

Status:

Treatment and prevention of mastitis cattle

Read More

Animal Medicine

Rezovet-P®

Status:

Prevention and treatment of animals in bacterial diseases

Read More

Animal Medicine

Endorezor®

Status:

Treatment and prevention of cattle endometrit

Read More

Animal Medicine

Rezohoof®

Status:

Prevention and treatment of animals in diseases of the hoof

Read More

Animal Medicine

Rezoakva®

Status:

Prevention and treatment of fish for bacterial diseases

Read More

Animal Medicine

Rezoderm®

Status:

Treatment of animals for skin diseases and burns

Read More

Animal Medicine

Rezovet-D®

Status:

Prevention and treatment of dogs in bacterial diseases

Read More

Statuses of drugs for animals

Drugs for humans

Human Medicine

Rezovet-H®

Status:

Prevention and treatment of humans in bacterial diseases

Read More

Human Medicine

Rezoderm-H®

Status:

Treatment of humans for skin diseases and burns

Read More

Human Medicine

Rezomast-H®

Status:

Treatment and prevention of mastitis in humans

Read More

Human Medicine

Endorezor-H®

Status:

Prevention and treatment of endometritis in humans

Read More

Statuses of drugs for humans

Clinical tests
R&D
Laboratory tests
Patenting
Phase 1
Phase 2
Phase 3
R&D
Laboratory tests
Patenting
Phase 1
Phase 2
Phase 3
Clinical tests

Results of production tests

Results of Rezovet®

The obtained results of the study of the use of Rezovet in production conditions give grounds for its use as an effective tool for the prevention and treatment of such bacterial infections as: hemophilosis, colibacillosis, mycoplasmosis, pasteurellosis, pullorosis, necrotic enteritis, salmonellosis and its use in the standard scheme of poultry rearing.

Results of Rezomast®

Rezomast does not contain antibiotics, does not have waiting periods for milk, has a stable and long-lasting therapeutic efficacy, helps to stop inflammatory changes in the breast tissue and reduces the risk of recurrence of the disease. The results of the study of the use of Rezomast in industrial conditions give grounds for its use as an effective tool for the treatment of subclinical and clinical mastitis.